Blaise W Menta1,2,3, Russell H Swerdlow4,5,6,7,8,9. 1. University of Kansas Alzheimer's Disease Center, Fairway, KS, USA. 2. Neuroscience Graduate Program, University of Kansas Medical Center, Lawrence, KS, USA. 3. Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Lawrence, KS, USA. 4. University of Kansas Alzheimer's Disease Center, Fairway, KS, USA. rswerdlow@kumc.edu. 5. Neuroscience Graduate Program, University of Kansas Medical Center, Lawrence, KS, USA. rswerdlow@kumc.edu. 6. Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Lawrence, KS, USA. rswerdlow@kumc.edu. 7. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Lawrence, KS, USA. rswerdlow@kumc.edu. 8. Department of Neurology, University of Kansas Medical Center, Lawrence, KS, USA. rswerdlow@kumc.edu. 9. Landon Center on Aging, MS 2012, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. rswerdlow@kumc.edu.
Abstract
Alzheimer's disease (AD) is a neurodegenerative disease that devastates the lives of its victims, and challenges the family members and health care infrastructures that care for them. Clinically, attempts to understand AD have focused on trying to predict the presence of, and more recently demonstrate the presence of, its characteristic amyloid plaque and neurofibrillary tangle pathologies. Fundamental research has also traditionally focused on understanding the generation, content, and pathogenicity of plaques and tangles, but in addition to this there is now an emerging independent interest in other molecular phenomena including apolipoprotein E, lipid metabolism, neuroinflammation, and mitochondrial function. While studies emphasizing the role of these phenomena have provided valuable AD insights, it is interesting that at the molecular level these entities extensively intertwine and interact. In this review, we provide a brief overview of why apolipoprotein E, lipid metabolism, neuroinflammation, and mitochondrial research have become increasingly ascendant in the AD research field, and present the case for studying these phenomena from an integrated perspective.
Alzheimer's disease (n class="Disease">AD) is a neurodegenerative disease that devastates the lives of its victims, and challenges the family members and health care infrastructures that care for them. Clinically, attempts to understand AD have focused on trying to predict the presence of, and more recently demonstrate the presence of, its characteristic amyloid plaque and neurofibrillary tangle pathologies. Fundamental research has also traditionally focused on understanding the generation, content, and pathogenicity of plaques and tangles, but in addition to this there is now an emerging independent interest in other molecular phenomena including apolipoprotein E, lipid metabolism, neuroinflammation, and mitochondrial function. While studies emphasizing the role of these phenomena have provided valuable AD insights, it is interesting that at the molecular level these entities extensively intertwine and interact. In this review, we provide a brief overview of why apolipoprotein E, lipid metabolism, neuroinflammation, and mitochondrial research have become increasingly ascendant in the AD research field, and present the case for studying these phenomena from an integrated perspective.
Authors: H Hamanaka; Y Katoh-Fukui; K Suzuki; M Kobayashi; R Suzuki; Y Motegi; Y Nakahara; A Takeshita; M Kawai; K Ishiguro; M Yokoyama; S C Fujita Journal: Hum Mol Genet Date: 2000-02-12 Impact factor: 6.150
Authors: J A Morrow; M L Segall; S Lund-Katz; M C Phillips; M Knapp; B Rupp; K H Weisgraber Journal: Biochemistry Date: 2000-09-26 Impact factor: 3.162
Authors: S M Fullerton; A G Clark; K M Weiss; D A Nickerson; S L Taylor; J H Stengârd; V Salomaa; E Vartiainen; M Perola; E Boerwinkle; C F Sing Journal: Am J Hum Genet Date: 2000-09-13 Impact factor: 11.025